Skip to content

Lifecore Biomedical, Inc. LFCR Accumulated Depreciation

Accumulated Depreciation at other companies

ADMA Biologics logo
ADMA BiologicsADMA
$40M+12.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$671K
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$1.52B+10.7%
Baxter International logo
Baxter InternationalBAX
Charles River Laboratories logo
Charles River LaboratoriesCRL
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s accumulated depreciation?
Lifecore Biomedical, Inc. (LFCR) reported accumulated depreciation of $60.62M in Q1 2026.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.